vimarsana.com

Page 6 - Axonics Modulation Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

$32 5 Million for Irvine Device Maker - Orange County Business Journal

Global Bowel Stimulators Market to Grow with a CAGR of

Axonics raises 2022 sales guidance on Street-beating Q1

Axonics Modulation Technologies reported first-quarter financial results that topped analysts' consensus forecast.

Critical Comparison: Pulmonx (NASDAQ:LUNG) and Axonics (NASDAQ:AXNX)

Pulmonx (NASDAQ:LUNG – Get Rating) and Axonics (NASDAQ:AXNX – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Profitability This table compares Pulmonx and Axonics’ net margins, return on equity […]

Financial Survey: Axonics (NASDAQ:AXNX) and Pulmonx (NASDAQ:LUNG)

Axonics (NASDAQ:AXNX – Get Rating) and Pulmonx (NASDAQ:LUNG – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations and institutional ownership. Profitability This table compares Axonics and Pulmonx’s net margins, return on equity […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.